Search

Your search keyword '"Bindslev‐Jensen, Carsten"' showing total 863 results

Search Constraints

Start Over You searched for: Author "Bindslev‐Jensen, Carsten" Remove constraint Author: "Bindslev‐Jensen, Carsten"
863 results on '"Bindslev‐Jensen, Carsten"'

Search Results

2. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.

5. Identification of Potentially Tolerated Fish Species by Multiplex IgE Testing of a Multinational Fish-Allergic Patient Cohort

8. Managing food allergy: GA2LEN guideline 2022

10. Prehospital and In-Hospital Treatment with Adrenaline and Related Prognosis in Anaphylaxis Patients.

11. Challenge‐verified thresholds for allergens mandatory for labeling: How little is too much for the most sensitive patient?

12. Multinational study of allergic sensitization to ten fish species indicates patient-dependent tolerance of specific fish

16. COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

17. Międzynarodowe wytyczne EAACI/GA2LEN/EuroGuiDerm/ APAAACI dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki.

18. Detection of Sensitization Profiles with Cellular In Vitro Tests in Wheat Allergy Dependent on Augmentation Factors (WALDA).

19. Real-Life Adherence to Venom Immunotherapy and Adrenaline Autoinjector.

20. EAACI guidelines on the diagnosis of IgE‐mediated food allergy

23. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

25. Factors associated with venom immunotherapy side‐effects, re‐sting reactions, and adherence in real‐life.

26. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

27. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

32. In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria

36. Updated guidance regarding the risk ofAllergic reactions to COVID-19 vaccines and recommended evaluation and management: a GRADE assessment, and international consensus approach

38. Supplemental Table S3 from Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

39. Data from Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

41. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes

43. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

44. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative.

45. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

46. A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis

47. Short‐term real‐world experience with baricitinib treatment in Danish adults with moderate–severe atopic dermatitis

49. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

50. The ARIA-MASK-air® approach

Catalog

Books, media, physical & digital resources